Synapse

← Mathew S. Maurer

Papers by Mathew S. Maurer

Page 4 · newest first

  1. TTR (Transthyretin) Stabilizers Are Associated With Improved Survival in Patients With TTR Cardiac AmyloidosisCirculation Heart Failure · 2018
  2. Can a Left Ventricular Assist Device in Individuals with Advanced Systolic Heart Failure Improve or Reverse Frailty?Journal of the American Geriatrics Society · 2017
  3. Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier?Amyloid · 2017
  4. Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patientsScience Translational Medicine · 2017
  5. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacementEuropean Heart Journal · 2017
  6. Refining Low Physical Activity Measurement Improves Frailty Assessment in Advanced Lung Disease and Survivors of Critical IllnessAnnals of the American Thoracic Society · 2017
  7. Race, Ethnicity, Health Insurance, and Mortality in Older Survivors of Critical IllnessCritical Care Medicine · 2017
  8. Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosisAmyloid · 2017
  9. Syncope in older adults.2016
  10. Transcatheter Interatrial Shunt Device for the Treatment of Heart FailureCirculation Heart Failure · 2016
  11. Review and Analysis of Existing Mobile Phone Apps to Support Heart Failure Symptom Monitoring and Self-Care Management Using the Mobile Application Rating Scale (MARS)JMIR mhealth and uhealth · 2016
  12. Transthyretin Cardiac Amyloidosis in Black AmericansCirculation Heart Failure · 2016
  13. Rapidly Progressive Transthyretin-Mediated Amyloidosis in a Domino Liver Transplant Recipient of a Ser23Asn DonorJournal of Clinical Neuromuscular Disease · 2016
  14. Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin AmyloidosisNeurology and Therapy · 2016
  15. Results of Phase I Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with AL AmyloidosisBlood · 2015
  16. Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fractionEuropean Heart Journal · 2015
  17. Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy)Amyloid · 2015
  18. Tafamidis in Transthyretin Amyloid CardiomyopathyCirculation Heart Failure · 2015
  19. The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosisAmyloid · 2014
  20. Cardiac dysfunction in β-carotene-15,15′-dioxygenase-deficient mice is associated with altered retinoid and lipid metabolismAJP Heart and Circulatory Physiology · 2014
  21. Cardiovascular effects of hemoglobin response in patients receiving epoetin alfa and oral iron in heart failure with a preserved ejection fraction.2014
  22. Quantification of Transthyretin Kinetic Stability in Human Plasma Using Subunit ExchangeBiochemistry · 2014
  23. Quality of life impacts on 16‐year survival of an older ethnically diverse cohortInternational Journal of Geriatric Psychiatry · 2013
  24. The prognostic significance of central hemodynamics in patients with cardiac amyloidosisAmyloid · 2013
  25. Comparison of Cardiac Amyloidosis Due to Wild-Type and V122I Transthyretin in Older Adults Referred to an Academic Medical CenterAging Health · 2013
  26. 99m Tc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac AmyloidosesCirculation Cardiovascular Imaging · 2013
  27. Treating Anemia in Older Adults With Heart Failure With a Preserved Ejection Fraction With Epoetin AlfaCirculation Heart Failure · 2012
  28. THAOS – The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosisCurrent Medical Research and Opinion · 2012
  29. The Transthyretin Amyloidosis Outcomes Survey (THAOS) registry: design and methodologyCurrent Medical Research and Opinion · 2012
  30. Diflunisal for ATTR Cardiac AmyloidosisCongestive Heart Failure · 2012
  31. Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature reviewAmyloid · 2011
  32. Severe Dilated Cardiomyopathy in a Patient With Myotonic Dystrophy Type 2 and Homozygous Repeat Expansion in ZNF9Congestive Heart Failure · 2011
  33. Circulating Activated and Effector Memory T Cells Are Associated with Calcification and Clonal Expansions in Bicuspid and Tricuspid Valves of Calcific Aortic StenosisThe Journal of Immunology · 2011
  34. Blood Volume Measurements in Patients With Heart Failure and a Preserved Ejection Fraction: Implications for Diagnosing AnemiaCongestive Heart Failure · 2011
  35. Peak Cardiac Power Measured Noninvasively With a Bioreactance Technique Is a Predictor of Adverse Outcomes in Patients With Advanced Heart FailureCongestive Heart Failure · 2010
  36. Maximum Daily 6 Minutes of Activity: An Index of Functional Capacity Derived from Actigraphy and Its Application to Older Adults with Heart FailureJournal of the American Geriatrics Society · 2010
  37. The Effect of Erythropoietin on Exercise Capacity, Left Ventricular Remodeling, Pressure‐Volume Relationships, and Quality of Life in Older Patients With Anemia and Heart Failure With Preserved Ejection FractionCongestive Heart Failure · 2009
  38. Absence of Heart Failure in Severe Cardiac and Autonomic Amyloidosis: The Essential Role of Sympathetic Activation and Venous Tone in the Development of the Congestive Heart Failure SyndromeCongestive Heart Failure · 2009
  39. Predictors of survival in patients with systemic light‐chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasoneBritish Journal of Haematology · 2008
  40. Self-Reported Lack of Energy (Anergia) Among Elders in a Multiethnic CommunityThe Journals of Gerontology Series A · 2008
  41. Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health StudyEuropean Heart Journal · 2008
  42. The Lymphocytic Infiltration in Calcific Aortic Stenosis Predominantly Consists of Clonally Expanded T CellsThe Journal of Immunology · 2007
  43. Cardiac Transplantation Using Extended-Donor Criteria Organs for Systemic Amyloidosis Complicated by Heart FailureTransplantation · 2007
  44. The Cardio‐Renal‐Anemia Syndrome in Elderly Subjects With Heart Failure and a Normal Ejection Fraction: A Comparison With Heart Failure and Low Ejection FractionCongestive Heart Failure · 2006
  45. Development of Heart Failure in Chronic Hypertensive Dahl RatsHypertension · 2006
  46. Single-beat estimation of end-diastolic pressure-volume relationship: a novel method with potential for noninvasive applicationAJP Heart and Circulatory Physiology · 2006
  47. A Clinical Algorithm to Differentiate Heart Failure With a Normal Ejection Fraction by Pathophysiologic MechanismThe American Journal of Geriatric Cardiology · 2006
  48. Diabetes Mellitus Is Associated With an Increased Risk of Falls in Elderly Residents of a Long-Term Care FacilityThe Journals of Gerontology Series A · 2005
  49. Arterial Stiffness in Mild Primary HyperparathyroidismThe Journal of Clinical Endocrinology & Metabolism · 2005
  50. Assessment of Age‐Related Changes in Left Ventricular Structure and Function by Freehand Three‐Dimensional EchocardiographyThe American Journal of Geriatric Cardiology · 2005